Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | M6PR | P20645 | 2/20 | 0.44 |
| ▸ | MGAM | O43451 | 4/20 | 0.40 |
| ▸ | SI | P14410 | 4/20 | 0.40 |
| ▸ | G6PD | P11413 | 2/20 | 0.38 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.38 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12070982 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL15215703 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL15121661 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL2505909 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL15273797 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL2233716 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL24605082 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL1832193 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL15273793 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL13509342 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108495656-B | Antibacterial composition containing deoxyhexose alkyl monoacetal or monoether | 特雷奥斯淀粉及甜味剂比利时公司 | 2021-02-02 | — | — | CN | claimed |
| US-20200281956-A1 | ANTIBACTERIAL COMPOSITION CONTAINING A DEOXYHEXOSE ALKYL MONOACETAL OR MONOETHER | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2020-09-10 | — | — | US | claimed |
| EP-3389731-B1 | ANTIBACTERIAL COMPOSITION CONTAINING A DEOXYHEXOSE ALKYL MONOACETAL OR MONOETHER | TEREOS STARCH & SWEETENERS BELGIUM (BE) | 2020-07-29 | — | — | EP | claimed |
| CN-111447940-A | Compositions and methods for preventing or treating radiation-induced bystander effects caused by radiation or radiotherapy | 科罗拉多大学评议会 | 2020-07-24 | — | — | CN | claimed |
| EP-3389731-A1 | ANTIBACTERIAL COMPOSITION CONTAINING A DEOXYHEXOSE ALKYL MONOACETAL OR MONOETHER | Tereos Starch & Sweeteners Belgium (BE) | 2018-10-24 | — | — | EP | claimed |
| CN-114340739-A | Composition for dyeing keratin fibres | 莱雅公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-114286712-A | Composition for dyeing keratin fibres | 莱雅公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-114269320-A | Composition for dyeing keratin fibers and use thereof | 莱雅公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-113613733-A | Topical, isotonic compositions for genital use | 葛莱赛欧米有限责任公司 | 2021-11-05 | — | — | CN | disclosed |
| CN-108495656-B | Antibacterial composition containing deoxyhexose alkyl monoacetal or monoether | 特雷奥斯淀粉及甜味剂比利时公司 | 2021-02-02 | — | — | CN | disclosed |
| US-20200281956-A1 | ANTIBACTERIAL COMPOSITION CONTAINING A DEOXYHEXOSE ALKYL MONOACETAL OR MONOETHER | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2020-09-10 | — | — | US | disclosed |
| EP-3389731-A1 | ANTIBACTERIAL COMPOSITION CONTAINING A DEOXYHEXOSE ALKYL MONOACETAL OR MONOETHER | Tereos Starch & Sweeteners Belgium (BE) | 2018-10-24 | — | — | EP | disclosed |
| EP-1642132-A2 | GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI | INSTITUT PASTEUR (FR) | 2006-04-05 | — | — | EP | disclosed |
| WO-2005003775-A2 | GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI | INSTITUT PASTEUR (FR) | 2005-01-13 | — | — | WO | disclosed |
| US-20040171524-A1 | Lectin-directed prodrug delivery system | ISIS INNOVATION LIMITED (GB) | 2004-09-02 | — | — | US | disclosed |
| EP-1372734-A1 | LECTIN-DIRECTED PRODRUG DELIVERY SYSTEM | ISIS INNOVATION LIMITED (GB) | 2004-01-02 | — | — | EP | disclosed |
| WO-2002080980-A1 | LECTIN-DIRECTED PRODRUG DELIVERY SYSTEM | ISIS INNOVATION LIMITED (GB) | 2002-10-17 | — | — | WO | disclosed |
| EP-0341684-B1 | Human monoclonal antibody, hybridoma producing the same and pharmaceutical | SUMITOMO PHARMA (JP) | 1995-01-18 | — | — | EP | disclosed |
| US-5252480-A | Treatment of infectious diseases caused by pseudomonas aeruginosa | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-10-12 | — | — | US | disclosed |
| EP-0341684-A2 | Human monoclonal antibody, hybridoma producing the same and pharmaceutical | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1989-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200281956-A1 | ANTIBACTERIAL COMPOSITION CONTAINING A DEOXYHEXOSE ALKYL MONOACETAL OR MONOETHER | DPM1, GNE, DERA | M6PR 270/4885MGAM 11/4885SI 378/4885 |
| US-20040171524-A1 | Lectin-directed prodrug delivery system | ENGASE, SIGLEC7, ST6GAL1 | M6PR 123/4885MGAM 80/4885SI 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.